Year 2022 / Volume 29 / Number 1

PDF HTML

Avances en Dolor

Pharmacological interventions in fibromyalgia; current considerations

Rev. Soc. Esp. Dolor. 2022; 29(1): 6-7 / DOI: 10.20986/resed.2022.4001/2022

Leonardo Arce, Diana Alejandra Méndez






Complete Article

New comment

Security code:
CAPTCHA code image
Speak the codeChange the code
 

Comments

No comments in this article

References

1. Nijs J, Lahousse A, Kapreli E, Bilika P, Saraçoğlu İ, Malfliet A, et al. Nociplastic Pain Criteria or Recognition of Central Sensitization? Pain Phenotyping in the Past, Present and Future. J Clin Med. 2021;10(15):3203.
DOI: 10.3390/jcm10153203
2. Kosek E, Clauw D, Nijs J, Baron R, Gilron I, Harris RE, et al. Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain. 2021;162(11):2629-34.
DOI: 10.1097/j.pain.0000000000002324
3. Metyas S, Chen C, Joseph M, Hanna N, Basta J, Khalil A. Subcategories of Fibromyalgia - A New Concept. Curr Rheumatol Rev. 2022. DOI: 10.2174/2666255815666220225103234.
DOI: 10.2174/2666255815666220225103234
4. Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, et al. AAPT Diagnostic Criteria for Fibromyalgia. J Pain 2019;20(6):611-28.
DOI: 10.1016/j.jpain.2018.10.008
5. Arce L, Rodríguez LM. Estimulación eléctrica nerviosa transcutánea (TENS) como manejo efectivo del dolor y la fatiga en mujeres con fibromialgia . Rev Soc Esp Dolor. 2021;28(2):117. DOI: 10.20986/resed.2021.3931/2021.
DOI: 10.20986/resed.2021.3931/2021
6. Tzadok R, Ablin JN. Current and Emerging Pharmacotherapy for Fibromyalgia. Pain Res Manag. 2020;2020:6541798.
DOI: 10.1155/2020/6541798
7. Farag HM, Yunusa I, Goswami H, Sultan I, Doucette JA, Eguale T. Comparison of Amitriptyline and US Food and Drug Administration–Approved Treatments for Fibromyalgia: A Systematic Review and Network Meta-analysis. JAMA Netw Open. 2022;5(5):e2212939.
DOI: 10.1001/jamanetworkopen.2022.12939

Related articles

Citation tools

Arce L, Méndez D. Pharmacological interventions in fibromyalgia; current considerations. Rev Soc Esp Dolor 2022; 29(1): 6-7 / DOI: 1020986/resed20224001/2022


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics

This article has received 10740 visits.
This article has been downloaded 6 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 13/06/2022

Accepted: 06/07/2022

Online First: 08/07/2022

Published: 05/08/2022

Article Online First time: 25 days

Article editing time: 53 days


Share

This article hasn't been rated yet.
Reader rating:
Rate this article:
Send by e-mail
© 2025 Revista de la Sociedad Española del Dolor
ISSN: 1134-8046   e-ISSN: 2254-6189

       Indexed in:
Legal Notice